Adult AuDHD Evaluation in California
Comprehensive integrated evaluation and a personalized care plan for AuDHD adults in California
Designed to give you the diagnostic clarity you've been looking for and a clear path forward with your local prescriber.
California has a relatively neurodivergent-aware healthcare landscape compared to most states — but specialty integrated AuDHD evaluation is still rare, and most local providers either evaluate one neurotype at a time or charge premium prices for fragmented care. Sophisticated patients often arrive at evaluation having done substantial self-research and frustrated by clinicians who know less than the patient does.
Neurokin offers integrated AuDHD evaluation by telehealth for adults across California. Three visits, comprehensive assessment of both autism and ADHD, integrated diagnosis, and a detailed written care plan your local prescriber can use to manage your treatment going forward.
In California, we're licensed for evaluation and care planning. Prescribing happens through your local provider — most patients coordinate easily with their existing PCP or psychiatrist using our care plan as the clinical guide. Same evaluation depth as our NJ/NY service, same price ($2,500), different prescribing pathway.

Adult AuDHD Evaluation in California, Designed for Adults Who Don't Fit Either Label Alone
Neurokin works with AuDHD adults in California who are looking for evaluation that takes both neurotypes seriously. You might be a good fit if you're:
A California professional in cyclical burnout. Federal employee, attorney, policy professional, healthcare worker, or anyone navigating demanding masking-heavy work environments where deep burnout follows every successful project cycle.
An adult identified with one but suspecting both. ADHD diagnosis years ago that helped some things but never fully explained your social fatigue and sensory experiences — or autism identification that didn't account for executive function struggles.
A late-identified adult with complex presentation. Especially women, AFAB individuals, and high-masking adults whose AuDHD has been missed by single-neurotype evaluations.
An adult with multiple prior diagnoses. Anxiety, depression, OCD, BPD that didn't fully resolve with treatment — sometimes because AuDHD better explains the underlying pattern.
An adult who wants integrated evaluation without leaving California. Telehealth-based evaluation that doesn't require travel or fitting into a fragmented local system.
Many California patients come to us after navigating the local healthcare system without finding integrated AuDHD evaluation. We work with patients across California, including those who travel into the city for work and need flexible telehealth scheduling.
Integrated AuDHD Evaluation, by Telehealth, in California
AuDHD evaluation at Neurokin is collaborative, integrated, and grounded in your lived experience. The evaluation process and clinical depth are identical to what we offer in NJ and NY — same three visits, same five hours of clinical time, same comprehensive assessment of both neurotypes.
What's different in California is the prescribing pathway: instead of Karina managing medications directly, your local prescriber takes that role using our care plan as the clinical guide.
Our California AuDHD evaluations include:
Comprehensive clinical interviews and integrated developmental history (about 5 hours total clinical time)
ADHD-specific assessment tools (ASRS-v1.1, Conners' Adult Rating Scales, QbCheck when relevant)
Autism-specific assessment tools (RAADS-R, AQ-50, CAT-Q for masking)
Cognitive testing with Creyos when appropriate
In-depth exploration of the AuDHD interaction patterns
Co-occurring conditions assessment
How the Care Plan Works with Your Local Prescriber
The care plan you receive at Visit 3 is designed specifically for your local prescriber to use as a clinical guide.
What the integrated care plan includes:
Diagnostic conclusions for both neurotypes (autism, ADHD, and the AuDHD-specific interaction patterns)
Specific medication recommendations for ADHD components and any co-occurring conditions, including dosing considerations and monitoring guidance
Sensory strategies and accommodations relevant to your specific AuDHD profile
Executive function tools designed for an AuDHD brain (not just ADHD or just autism approaches)
Notes on how the two neurotypes might affect each other in treatment (where stimulants might amplify sensory sensitivity, where rigid routines might exacerbate ADHD-related shutdown)
Follow-up cadence recommendations

How most California patients coordinate this:
Most patients bring the care plan to their existing PCP, psychiatrist, or therapist. The care plan is detailed enough that most local prescribers can pick up directly from it without needing additional consultation.
If your local prescriber wants to talk to Karina directly with questions about how to interpret the AuDHD findings, our office facilitates that. If you don't have a current local prescriber, we can suggest what to look for when finding one.
Care plan updates over time:
If your care plan needs updating later (new circumstances, medication changes, or refinement based on what's working), you can return for a follow-up visit ($175) — telehealth — to revise the plan with Karina before bringing it back to your local prescriber. Most patients do this once or twice a year.
The Neurokin Advantage for AuDHD Evaluation in California
Identity-affirming, integrated care
We approach AuDHD as a complex form of neurodiversity. Both neurotypes matter. Strengths matter as much as challenges.
Specialty depth that local California providers often can't offer
Most California providers don't specialize in AuDHD specifically. We do.
Validated assessment tools for both neurotypes
Validated assessment tools for both neurotypes
Coordination support with your local prescriber
Our office can communicate directly with your local provider if questions come up about how to apply the AuDHD findings.
Telehealth designed for AuDHD
Video evaluation is often easier for AuDHD adults than in-person clinical settings — no sensory overload from medical office environments, no travel-related executive function tax.
Discreet, professional environment
For California AuDHD adults who value privacy — federal employees, attorneys, policy professionals — we offer a modern, respectful experience without insurance documentation or shared system records.

Where We Practice
NJ & NY
Full Care
Comprehensive evaluation, diagnosis, treatment planning, and ongoing prescribing.
DC, FL & CA
Diagnostic & Care Plan
Comprehensive evaluation and a written care plan that you'll use with your local prescriber.

Serving AuDHD Adults Throughout California
Neurokin provides AuDHD evaluation and care plan support for adults throughout California via telehealth — including all neighborhoods within the District.
Our California patients include federal employees, attorneys, policy professionals, healthcare workers, and other professionals navigating the demanding masking environments common in the city. AuDHD shows up disproportionately in these populations, and integrated evaluation often makes sense of patterns that single-neurotype assessment misses.
If you live in California but work cross-jurisdictionally (Maryland, Virginia), we can usually still serve you — California residency is what matters for licensure. If you're in Maryland or Virginia and considering California-based services, contact us to discuss options.
Real Patients, Real Progress
Begin Your Journey to Integrated Understanding in California
If you're looking for AuDHD evaluation in California that takes both autism and ADHD seriously — same depth as our NJ/NY service, with care plan handoff to your local prescriber — Neurokin is here.
You don't need to be certain whether it's AuDHD before you reach out. You don't need to have it figured out. You need a place that takes both halves of your experience seriously and can give you a clear path forward.
Your Questions About AuDHD Evaluation in California, Answered
How do I get an AuDHD evaluation in California?
AuDHD is the term used when a person meets diagnostic criteria for both autism and ADHD. "Au" for autism, "DHD" for ADHD — pronounced "oh-D-H-D." It's not a separate condition from autism or ADHD; it's the recognition that the two neurotypes co-occur often (in 30-50 percent of autistic adults and a similar proportion of adults with ADHD) and interact distinctly enough that thinking of them together usually serves people better than thinking of them apart.
Why don't you prescribe in California?
The two neurotypes interact in ways that don't fit either single label. Common AuDHD patterns include sensory sensitivity AND sensory seeking, craving routine AND craving novelty, deep hyperfocus AND difficulty starting tasks, masking AND impulsivity. These contradictions are part of the AuDHD signature — and they're often why single-neurotype evaluations miss it.
Is the evaluation different from what you offer in NJ or NY?
Yes. Many AuDHD evaluations start without prior diagnosis of either condition. If both neurotypes are present, AuDHD evaluation is more efficient and accurate than separate ADHD and autism evaluations done sequentially. We assess for both at the same time.
How does coordination with my local prescriber work?
If you've consistently felt that ADHD didn't fully explain your experience — sensory sensitivities, social fatigue, special interests, masking patterns, struggles that ADHD treatment didn't fully address — AuDHD evaluation often makes sense. Re-evaluation can clarify whether autism was missed and how that changes your care plan going forward.
What if I don't have a local prescriber yet?
Three visits over three to four weeks. About five hours of clinical time total — longer than ADHD-only or autism-only evaluation because both neurotypes need their own depth of assessment in the same evaluation.
Is the price the same as what you charge in NJ or NY?
$2,500 total, paid across three visits ($900 + $800 + $800). The optional comprehensive written report adds $450 if you need formal documentation. We accept HSA/FSA cards directly and provide a superbill for out-of-network reimbursement. See our Pricing page for full details.
How long does AuDHD evaluation take?
That can happen. Sometimes what seems like AuDHD is actually one neurotype with confounding factors (anxiety, trauma response, masking presenting differently than expected). If we identify only one neurotype, your care plan reflects that — and we'll discuss the pricing implications transparently. If we find ADHD only, the evaluation completes as an ADHD evaluation. If we find autism only, similarly. We don't charge AuDHD pricing for non-AuDHD findings.
What's included in the integrated care plan?
AuDHD itself isn't medication-treated — medication is for specific symptoms or co-occurring conditions, not for autism or ADHD as identities. ADHD-specific medications (stimulants, non-stimulants) can help with the ADHD-related challenges. Co-occurring anxiety, depression, or sleep issues may benefit from their own medication treatment. Autism doesn't have a primary medication treatment. Karina prescribes for the ADHD and co-occurring components in NJ and NY; in DC, FL, and CA, your local prescriber handles medication management using our care plan.
Can I get the comprehensive written report for accommodations?
Yes. The full three-visit AuDHD evaluation can be done by telehealth in any of our five licensed states (NJ, NY, DC, FL, CA). In-person is available at our Westfield NJ and Midtown Manhattan offices. Telehealth works well for AuDHD evaluation because most of the work is conversation and assessment tools that translate cleanly to video.
What happens after my evaluation?
You receive an integrated diagnostic picture, a written care plan addressing both neurotypes, and time to ask every question. In NJ or NY, you can stay in care with Karina for ongoing support including any prescribing. In DC, FL, or CA, your care plan is the clinical guide your local prescriber uses for any medications. Either way, you walk away with clarity and a concrete plan for what comes next.